NCT02932345 - Gefitinib Long-term Survivor Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

July 4, 2017

Study Completion Date

July 4, 2017

Conditions

EGFR Mutation Positive Advanced Non-small-cell Lung Cancer

Trial Locations (14)

Research Site, Beijing

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Shijiazhuang

Research Site, Zhengzhou

Research Site, Wuhan

Research Site, Nanjing

Research Site, Changchun

Research Site, Shenyang

Research Site, Xi'an

Research Site, Shanghai

Research Site, Taiyuan

Research Site, Chengdu

Research Site, Hangzhou